Furthermore, numerous studies have indicated that cancer cells with an active UPR can drastically alter the function of the immune cells including natural killer cells, macrophages, T-cells, and myeloid cells in the TME mainly through the IRE1-XBP1s driven expression of the proinflammatory factors as well as the PERK signals. Here, EIF2AK3 is linked to cancer.